Wayne M. Yokoyama
NIH Rank #589
- Top 5% Funded
- R01 Holder
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8404502Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$8.3M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#589
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Wayne M. Yokoyama as a PI. Multi-PI records show the full award amount for context.
- 1R01CA303538-01R01Natural killer cells subvert immune checkpoint therapy of tumors$3.2Maward amount
- 1T32GM154644-01T32National Research Service Award-Medical Scientist$2.6Maward amount
- 4R01AI131680-09R01Natural Killer Cell Control of Murine Cytomegalovirus Infection$1.3Maward amount
- $577.8Kaward amount
- 5R38AI174266-03R38Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University$540Kaward amount
- $165.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing Wayne M. Yokoyama as a PI.
FY2025 award administered by Washington University in St. Louis (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWashington University in St. Louis
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1205
- 2024Entered Top 25% NationallyRanked #1205
- 2024Entered Top 10% NationallyRanked #1205
- 2025$5M Cumulative Funding
- 2025$10M Cumulative Funding
- 2025Entered Top 5% NationallyRanked #589
- 2025R01 Grant Holder